Axonal ion channel dysfunction in c9orf72 familial amyotrophic lateral sclerosis.

IMPORTANCE Abnormalities of axonal excitability characterized by upregulation of persistent sodium (Na+) conductances and reduced potassium (K+) currents have been reported in sporadic amyotrophic lateral sclerosis (SALS) phenotypes and linked to the development of clinical features such as fasciculations and neurodegeneration. OBJECTIVE To investigate whether abnormalities of axonal ion channel function, particularly upregulation of persistent Na+ conductances and reduced K+ currents, form the pathophysiological basis of chromosome 9 open reading frame 72 (c9orf72) familial amyotrophic lateral sclerosis (FALS). DESIGN, SETTING, AND PARTICIPANTS This was a prospective study. Clinical and functional assessment, along with motor-nerve excitability studies, were undertaken in 10 clinically affected patients with c9orf72 FALS, 9 asymptomatic c9orf72 mutation carriers, and 21 patients with SALS from 3 hospitals and 2 outpatient clinics. MAIN OUTCOMES AND MEASURES Axonal excitability variables were measured in patients with c9orf72 ALS and results compared with matched patients with SALS and healthy control participants. RESULTS Strength-duration time constant (τSD) was significantly increased in the patients with c9orf72 FALS and those with SALS (mean [SD], c9orf72 FALS: 0.50 [0.02] milliseconds; SALS: 0.52 [0.02] milliseconds; P < .01) when compared with control participants (mean [SD], 0.44 [0.01] milliseconds). In contrast, there were no significant changes of τSD in asymptomatic c9orf72 mutation carriers (P = .42). An accompanying increase in depolarizing threshold electrotonus at 90 to 100 milliseconds (TEd 90-100 milliseconds) was also evident in the c9orf72 FALS (P < .05) and SALS (P < .01) cohorts. Mathematical modeling suggested that an increase in persistent Na+ conductances, along with reduced K+ currents, best explained the changes in axonal excitability. Importantly, these abnormalities in axonal excitability correlated with the motor amplitude (τSD: R = -0.38, P < .05 and TEd 90-100 milliseconds: R = -0.44, P < .01), muscle weakness (TEd 90-100 milliseconds: R = -0.32, P < .05), and the ALS Functional Rating Scale (TEd 90-100 milliseconds: R = -0.34, P < .05). CONCLUSIONS AND RELEVANCE Findings from the present study establish that upregulation of persistent Na+ conductances and reduced K+ currents were evident in both c9orf72 FALS and SALS cohorts, and these changes in axonal excitability were associated with motor neuron degeneration.

[1]  Robert H. Brown,et al.  Intrinsic membrane hyperexcitability of amyotrophic lateral sclerosis patient-derived motor neurons. , 2014, Cell reports.

[2]  M. Kiernan,et al.  ALS pathophysiology: Insights from the split-hand phenomenon , 2014, Clinical Neurophysiology.

[3]  D. Neary,et al.  Frontotemporal dementia with amyotrophic lateral sclerosis: A clinical comparison of patients with and without repeat expansions in C9orf72 , 2013, Amyotrophic lateral sclerosis & frontotemporal degeneration.

[4]  S. Kuwabara,et al.  Split hand syndrome in amyotrophic lateral sclerosis: different excitability changes in the thenar and hypothenar motor axons , 2013, Journal of Neurology, Neurosurgery & Psychiatry.

[5]  M. Kiernan,et al.  Pathophysiological insights into ALS with C9ORF72 expansions , 2013, Journal of Neurology, Neurosurgery & Psychiatry.

[6]  M. Swash,et al.  Fasciculation potentials and earliest changes in motor unit physiology in ALS , 2013, Journal of Neurology, Neurosurgery & Psychiatry.

[7]  M. Kiernan,et al.  Evolution of peripheral nerve function in humans: novel insights from motor nerve excitability , 2013, The Journal of physiology.

[8]  M. Kiernan,et al.  Progressive axonal dysfunction and clinical impairment in amyotrophic lateral sclerosis , 2012, Clinical Neurophysiology.

[9]  Sterling C. Johnson,et al.  Hexanucleotide repeat expansions in C9ORF72 in the spectrum of motor neuron diseases , 2012, Neurology.

[10]  Yasunori Sato,et al.  Motor axonal excitability properties are strong predictors for survival in amyotrophic lateral sclerosis , 2012, Journal of Neurology, Neurosurgery & Psychiatry.

[11]  Janel O. Johnson,et al.  Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study , 2012, The Lancet Neurology.

[12]  David Burke,et al.  The voltage dependence of Ih in human myelinated axons , 2012, The Journal of physiology.

[13]  Bruce L. Miller,et al.  Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS , 2011, Neuron.

[14]  David Heckerman,et al.  A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD , 2011, Neuron.

[15]  Ammar Al-Chalabi,et al.  Clinical genetics of amyotrophic lateral sclerosis: what do we really know? , 2011, Nature Reviews Neurology.

[16]  M. Kiernan,et al.  Dysfunction of axonal membrane conductances in adolescents and young adults with spinal muscular atrophy , 2011, Brain : a journal of neurology.

[17]  O. Hardiman,et al.  Amyotrophic lateral sclerosis , 2011, The Lancet.

[18]  K. Mills,et al.  Characteristics of fasciculations in amyotrophic lateral sclerosis and the benign fasciculation syndrome. , 2010, Brain : a journal of neurology.

[19]  Michael O'Brien,et al.  Aids to the examination of the peripheral nervous system: 6th edition , 2023, Practical Neurology.

[20]  M. Kiernan,et al.  Axonal ion channels from bench to bedside: A translational neuroscience perspective , 2009, Progress in Neurobiology.

[21]  M. Kiernan,et al.  Upregulation of persistent sodium conductances in familial ALS , 2009, Journal of Neurology, Neurosurgery & Psychiatry.

[22]  S. Kuwabara,et al.  Changes in Na+ channel expression and nodal persistent Na+ currents associated with peripheral nerve regeneration in mice , 2008, Muscle & nerve.

[23]  P. Stys Sodium channel blockers as neuroprotectants in neuroinflammatory disease: a double‐edged sword , 2007, Annals of neurology.

[24]  Stephen G. Waxman,et al.  Axonal conduction and injury in multiple sclerosis: the role of sodium channels , 2006, Nature Reviews Neuroscience.

[25]  S. Kuwabara,et al.  Increased nodal persistent Na+ currents in human neuropathy and motor neuron disease estimated by latent addition , 2006, Clinical Neurophysiology.

[26]  John R Hodges,et al.  The Addenbrooke's Cognitive Examination Revised (ACE‐R): a brief cognitive test battery for dementia screening , 2006, International journal of geriatric psychiatry.

[27]  H. Bostock,et al.  Distal excitability changes in motor axons in amyotrophic lateral sclerosis , 2006, Clinical Neurophysiology.

[28]  Matthew C. Kiernan,et al.  Axonal excitability properties in amyotrophic lateral sclerosis , 2006, Clinical Neurophysiology.

[29]  Peter K. Stys,et al.  General mechanisms of axonal damage and its prevention , 2005, Journal of the Neurological Sciences.

[30]  D. Burke,et al.  Acute tetrodotoxin‐induced neurotoxicity after ingestion of puffer fish , 2005, Annals of neurology.

[31]  M. Swash,et al.  Cramps, muscle pain, and fasciculations , 2004, Neurology.

[32]  P. Stys Axonal degeneration in multiple sclerosis: Is it time for neuroprotective strategies? , 2004, Annals of neurology.

[33]  F. Turkheimer,et al.  Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [11C](R)-PK11195 positron emission tomography study , 2004, Neurobiology of Disease.

[34]  S. Kuwabara,et al.  Muscle cramp in Machado-Joseph disease: altered motor axonal excitability properties and mexiletine treatment. , 2003, Brain : a journal of neurology.

[35]  D. Burke,et al.  Excitability of human axons , 2001, Clinical Neurophysiology.

[36]  N. Murray,et al.  Clinical evaluation of excitability measures in sensory nerve , 2001, Muscle & nerve.

[37]  A. Eisen Clinical Electrophysiology of the Upper and Lower Motor Neuron in Amyotrophic Lateral Sclerosis , 2001, Seminars in neurology.

[38]  H Bostock,et al.  Effects of temperature on the excitability properties of human motor axons. , 2001, Brain : a journal of neurology.

[39]  H. Bostock,et al.  Effects of membrane polarization and ischaemia on the excitability properties of human motor axons. , 2000, Brain : a journal of neurology.

[40]  D. Burke,et al.  Strength–duration properties and their voltage dependence as measures of a threshold conductance at the node of Ranvier of single motor axons , 2000, Muscle & nerve.

[41]  D. Burke,et al.  Multiple measures of axonal excitability: A new approach in clinical testing , 2000, Muscle & nerve.

[42]  M. Swash,et al.  Nerve conduction studies in amyotrophic lateral sclerosis , 2000, Muscle & nerve.

[43]  J. Cedarbaum,et al.  The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function , 1999, Journal of the Neurological Sciences.

[44]  D. Burke,et al.  Strength–duration properties and their voltage dependence at different sites along the median nerve , 1999, Clinical Neurophysiology.

[45]  D. Burke,et al.  Strength-duration properties of sensory and motor axons in amyotrophic lateral sclerosis. , 1998, Brain : a journal of neurology.

[46]  D. Burke,et al.  Threshold tracking techniques in the study of human peripheral nerve , 1998, Muscle & nerve.

[47]  P. Stys,et al.  Anoxic and Ischemic Injury of Myelinated Axons in CNS White Matter: From Mechanistic Concepts to Therapeutics , 1998, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[48]  D. Burke,et al.  Strength‐duration properties of sensory and motor axons in carpal tunnel syndrome , 1997, Muscle & nerve.

[49]  H Bostock,et al.  Low-threshold, persistent sodium current in rat large dorsal root ganglion neurons in culture. , 1997, Journal of neurophysiology.

[50]  P. Grafe,et al.  Abnormal axonal inward rectification in diabetic neuropathy , 1996, Muscle & nerve.

[51]  D Burke,et al.  Strength-duration properties of human peripheral nerve. , 1996, Brain : a journal of neurology.

[52]  Hugh Bostock,et al.  Action potentials and membrane currents in the human node of Ranvier , 1995, Pflügers Archiv.

[53]  H Bostock,et al.  Axonal ion channel dysfunction in amyotrophic lateral sclerosis. , 1995, Brain : a journal of neurology.

[54]  H Bostock,et al.  Changes in excitability of human motor axons underlying post‐ischaemic fasciculations: evidence for two stable states. , 1991, The Journal of physiology.

[55]  G. Roth,et al.  Fasciculations and their F-response Localisation of their axonal origin , 1984, Journal of the Neurological Sciences.

[56]  H Bostock,et al.  The strength‐duration relationship for excitation of myelinated nerve: computed dependence on membrane parameters. , 1983, The Journal of physiology.

[57]  G Roth,et al.  The origin of fasciculations , 1982, Annals of neurology.

[58]  中田 美保 Altered axonal excitability properties in amyotrophic lateral sclerosis , 2007 .

[59]  E. Kahana,et al.  Amyotrophic lateral sclerosis. A study of its presentation and prognosis , 2004, Journal of Neurology.

[60]  D. Burke,et al.  Threshold electrotonus and the assessment of nerve excitability in amyotrophic lateral sclerosis , 2004 .

[61]  Andrew Eisen,et al.  Clinical neurophysiology of motor neuron diseases , 2004 .

[62]  J. Rothwell,et al.  Latent addition in motor and sensory fibres of human peripheral nerve. , 1997, The Journal of physiology.

[63]  G. Weiss Sur la possibilite de rendre comparables entre eux les appareils servant a l'excitation electrique. , 1990 .